• EdU Imaging Kits (Cy3) for HNSCC S-Phase

  2026-08-19

  EdU Imaging Kits (Cy3) translate DNA replication into a bright Cy3 signal for microscopy, flow cytometry, and quantitative tumor-microenvironment studies. This practical guide adapts the assay to CCR7/DUSP1 iCAF experiments, co-culture models, drug-response screens, and genotoxicity testing while preserving morphology and antigen accessibility.

• (-)-JQ1 Controls for BRD4 Assays

  2026-08-19

  (-)-JQ1 is a cell-permeable JQ1 stereoisomer used to separate BET bromodomain engagement from vehicle, handling, and nonspecific treatment effects. This guide shows how to deploy it in BRD4-dependent cell line studies, epigenetics research, and inv(16) AML workflows inspired by a recent N-MYC/eIF4G1 study.

• SMPD4, Ceramide, and Primary Cilia in Brain Development

  2026-08-18

  The 2024 Development study identifies SMPD4-dependent ceramide production as a key requirement for primary-cilium formation, neural progenitor survival, and brain development. By combining a mouse model with human SMPD4-deficient induced pluripotent stem cells and a ceramide-rescue experiment, the authors connect sphingolipid metabolism to microcephaly and cerebellar hypoplasia.

• Ozone, Efferocytosis, and Neuropathic Pain

  2026-08-18

  Ruan et al. identify macrophage efferocytosis as a mechanistically important component of ozone-mediated relief of neuropathic pain. In a chronic constriction injury model and complementary macrophage experiments, ozone activated an AMPK/Gas6-MerTK/SOCS3 axis, increased apoptotic-cell clearance, and reduced inflammatory signaling, although translational validation remains necessary.

• G-15: GPR30 Antagonist Research Workflow

  2026-08-17

  G-15 is a selective G protein-coupled estrogen receptor antagonist for separating GPR30 signaling from ERα and ERβ activity. This workflow connects receptor pharmacology with calcium, PI3K/Akt, proliferation, endoplasmic-reticulum-stress, and immune-function readouts.

• PDE-5-Silenced BMSCs in Diabetic Cardiac Fibrosis

  2026-08-17

  The reference study shows that bone marrow mesenchymal stem cells with suppressed PDE-5 expression reduce high-glucose-associated fibrotic signaling and cardiomyocyte injury phenotypes in a co-culture model. Its central contribution is to connect BMSC-mediated cardiac protection with restoration of the cGMP/PKG pathway, while also highlighting the need for in vivo and pathway-blockade validation.

• Streptozotocin Workflows for Diabetes Research

  2026-08-16

  Streptozotocin enables controlled β-cell injury, hyperglycemia, and downstream diabetes-complication studies when formulation, dosing, and validation are tightly standardized. This workflow connects STZ-based metabolic models with modern pain, microglia, and pyroptosis assays while emphasizing practical troubleshooting and model limitations.

• Molidustat (BAY85-3934): HIF Assay Strategy

  2026-08-15

  Molidustat (BAY85-3934) is examined as a HIF prolyl hydroxylase inhibitor through a practical assay-design lens. This article connects renal anemia pharmacology with VHL-dependent HIF degradation biology while defining controls for interpreting HIF stabilization experiments.

• EdU Imaging Kits (Cy3): From Signal to Decision

  2026-08-14

  EdU Imaging Kits (Cy3) provide denaturation-free S-phase labeling for precise proliferation analysis. This guide shows how to interpret EdU results alongside HIF1A, apoptosis, and drug-response data in cholangiocarcinoma research.

• GTP Solution for Reliable mRNA Synthesis

  2026-08-14

  GTP Solution (100 mM) provides a ready-to-use, nuclease-free Guanosine-5'-triphosphate source for in vitro transcription, RNA amplification, and nucleotide-dependent assays. This guide connects practical stock handling and reaction optimization with the p21 mRNA–lipid nanoparticle workflow reported for localized bladder cancer research.

• NPC1/USP7/p53 Axis in Hepatocellular Carcinoma

  2026-08-13

  A 2026 Oncogene study identifies NPC1 as an oncogenic regulator in hepatocellular carcinoma through coordinated control of p53 stability and cholesterol metabolism. Its perturbation and rescue experiments connect NPC1, USP7, p53, and SREBP2 to tumor-cell proliferation, providing a mechanistic framework for studying metabolic drivers of HCC.

• 15-PGDH Inhibition Supports Muscle Repair During Weight Loss

  2026-08-13

  The reference study identifies 15-PGDH inhibition as a strategy for improving muscle stem cell activity, regenerated myofiber growth, and strength recovery during semaglutide-associated weight loss. Its mouse data suggest that combining a 15-PGDH inhibitor with a GLP-1 receptor agonist can improve postinjury muscle quality without eliminating the desired reduction in body weight.

• PID1, Oxysterols, and Macrophage Fate

  2026-08-12

  The reference study identifies PID1 as an immunometabolic regulator that restrains LDL uptake and cholesterol oxidation in tumor-associated macrophages. Myeloid Pid1 deficiency redirects cholesterol and reactive oxygen species toward 5α,6α-epoxycholesterol and 7β-hydroxycholesterol, weakening mTOR–STAT6–ARG1 signaling and improving CD8+ T cell-mediated tumor control. The work provides a mechanistic framework for studying cholesterol metabolism as a determinant of macrophage state, while distinguishing sterol profiling from membrane cholesterol imaging.

• Azilsartan: A Causal Map for Neuroinflammation

  2026-08-12

  Azilsartan (TAK-536) is more than an AT1 receptor blocker: it can serve as a causal probe for linking microglial signals, reactive astrocyte states, and RAS–SIRT3 biology. This article presents an evidence-led framework for designing and interpreting these assays without confusing pharmacological association with mechanism.

• Pollen Interference in EEM Bioaerosol Classification

  2026-08-11

  Zhang and colleagues developed a spectral-processing and random-forest workflow that reduces pollen interference when excitation–emission matrix fluorescence spectroscopy is used to classify hazardous biological substances. Fast Fourier transform processing increased classification accuracy by 9.2 percentage points to 89.24%, supporting more reliable rapid screening of mixed bioaerosol signals.

8647 records 10/577 page Previous Next First page 上5页 678910 下5页 Last page